Marilamed

Hydrochlorothiazide and Ramipril, the active ingredients in Marilamed, are an ACE inhibitor and thiazide diuretic combination presented as an oral tablet for adult use. It treats hypertension and associated edema in patients requiring blood pressure control.

GNH USA supplies Marilamed as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Marilamed, a combination of an ACE inhibitor and a thiazide diuretic, is used to manage conditions related to elevated blood pressure and fluid retention.

- Hypertension: lowers systolic and diastolic blood pressure, reducing cardiovascular risk. - Edema associated with hypertension: decreases excess fluid accumulation, relieving swelling. - Blood pressure control in patients with concomitant hypertension and fluid retention: provides combined antihypertensive and diuretic effects for more effective management.

Marilamed may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness or light‑headedness - Headache - Persistent dry cough - Increased urination or thirst - Electrolyte disturbances such as low potassium - Fatigue or weakness

Serious or Rare Side Effects: - Angioedema with swelling of face, lips or throat - Severe dehydration or electrolyte imbalance - Hyperkalemia leading to cardiac arrhythmia - Acute renal impairment or failure - Marked hypotension causing fainting - Anaphylactic or severe allergic reactions

Before prescribing Marilamed, clinicians should consider several safety precautions to minimize risks. - Monitor blood pressure: ensure adequate control and avoid excessive hypotension. - Assess renal function: check serum creatinine and eGFR prior to initiation and periodically thereafter. - Check electrolytes: especially potassium and sodium levels, adjusting therapy as needed. - Avoid use in pregnancy: the drug is classified as Category D and may harm the fetus. - Use caution in elderly: increased sensitivity to blood pressure changes and electrolyte shifts. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Marilamed can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Concomitant use of aliskiren in diabetic patients: risk of renal impairment and hyperkalemia. - Potassium‑sparing diuretics or supplements: may cause dangerous hyperkalemia. - NSAIDs (e.g., ibuprofen, naproxen): can reduce antihypertensive effect and impair renal function. - Lithium: increased lithium levels leading to toxicity. - Combined ACE inhibitor with ARB therapy: heightened risk of hypotension and renal dysfunction.

Moderate Interactions (Monitor Closely): - Other antihypertensives (beta‑blockers, calcium channel blockers): may enhance blood pressure lowering. - Digoxin: diuretic‑induced electrolyte changes can predispose to digoxin toxicity. - Antacids containing aluminum or magnesium: may decrease absorption of ramipril. - Thiazide diuretics with other diuretics: risk of excessive diuresis and electrolyte loss. - SSRIs (e.g., fluoxetine): potential for increased bleeding risk.